Multivariate analysis of the potential risk factors of atopic diseases. by Sheng-Feng Lin (9591995)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Associations between BCG-treated individuals and their controls across different subgroups and overall categories. by Eugen Wang (17636322)

Subjects:

Association of changes in MVPA between two biennial health screening periods (2013 to 2014 and 2015 to 2016) with risk of depression. by Su Kyoung Lee (457838)

Subjects:

The windows show the final results reflecting the increase or decrease in the GRF and JRF calculations. by Amany Eid Abd El-Tawab (13864185)

Table_1_Differences and Similarities in Motives to Decrease Drinking, and to Drink in General Between Former and Current Heavy Drinkers—Implications for Changing Own Drinking Behav... by Magdalena Rowicka (11935229)

“…Additionally, a set of questions regarding motives to decrease drinking were analysed. The results show that differences were observed between the investigated groups: the current dependent group scored significantly higher on all the dimensions of drinking motives than the current low-risk group and significantly higher on coping, social, and enhancement motives than former heavy drinkers (both groups). …”

Forest plots illustrate the mean difference in creatinine level with subgroup analysis based on patients’ age. by Mohamed R. Abdelraouf (21501468)

Subjects:

Cigarette lighter heating of <i>S</i>. <i>aureus</i>-"spiked" Hydromorphone-CR prepared in cookers/filters decreases the bacterial burden in the injected drug solution. by Katherine J. Kasper (7181015)

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Summary of risks, benefits, and examples of commercial products for major microbial genes. by Saiko Sugita (14581134)

Subjects:

Ranking of genotypes according to the ideotype for each trait and the percentage difference (increase or decrease) in relation to cv. M-82. by Herika Paula Pessoa (13254326)

Forest plot of the risk of TIR in HCL group versus control group. by Yuan-yuan WANG (19370071)

Subjects:

Sex-differentiated risk signal volcano plot for finasteride. by Xiaoling Zhong (181270)

Subjects:

Image_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Conclusion<p>Decreased EMT was independently associated with increased risk of PTB, LBW and SGA in women with PCOS.…”

Image_2_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.tif by Jialyu Huang (6742409)

“…</p>Conclusion<p>Decreased EMT was independently associated with increased risk of PTB, LBW and SGA in women with PCOS.…”

Table_1_Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.docx by Jialyu Huang (6742409)

“…</p>Conclusion<p>Decreased EMT was independently associated with increased risk of PTB, LBW and SGA in women with PCOS.…”

Associations between BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and in all categories. by Eugen Wang (17636322)

Subjects:

APOL1 risk variant expression in HeLa cells leads to lipid accumulation in the absence of decreased cholesterol efflux. by Jung-Hwa Ryu (512365)

“…There were no statistically significant differences in cholesterol efflux that were detected in this system.…”

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”